Ensysce Biosciences income statement data for the quarter ended Dec 2025. This income statement covers 33 quarters of results from Dec 2017 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||
| Revenue | 0.25M | 0.44M | 1.20M | 1.64M | 0.60M | 0.21M | 0.28M | 1.43M | 0.79M | 0.49M | 0.44M | 0.52M | 0.31M | 0.18M | 3.42M | 1.30M | 1.32M | 1.37M | 0.49M | ||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 0.28M | 0.46M | 1.71M | 2.19M | 3.14M | 5.31M | 4.76M | 6.44M | 1.80M | 1.64M | 1.91M | 2.23M | 0.78M | 0.95M | 1.69M | 3.80M | 1.89M | 1.92M | 2.95M | ||||||||||||||
| Selling, General & AdministrativeSG&A | 0.49M | 0.39M | 16.37M | 1.45M | 2.27M | 1.95M | 1.69M | 1.19M | 1.55M | 1.14M | 1.23M | 1.44M | 1.37M | 1.19M | 1.08M | 1.08M | 1.40M | 1.20M | 1.28M | ||||||||||||||
| Other Operating ExpensesOther Opex | |||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 0.77M | 0.86M | 18.09M | 3.64M | 5.41M | 7.26M | 6.44M | 7.63M | 3.35M | 2.78M | 3.14M | 3.67M | 2.15M | 2.14M | 2.77M | 4.88M | 3.29M | 3.12M | 4.23M | ||||||||||||||
| Operating IncomeOp. Inc | -0.52M | -0.41M | -16.89M | -2.01M | -4.80M | -7.06M | -6.16M | -6.20M | -2.56M | -2.29M | -2.71M | -3.16M | -1.84M | -1.96M | 0.64M | -3.58M | -1.97M | -1.75M | -3.74M | ||||||||||||||
| EBIT | -0.52M | -0.41M | -16.89M | -2.01M | -4.80M | -7.06M | -6.16M | -6.20M | -2.56M | -2.29M | -2.71M | -3.16M | -1.84M | -1.96M | 0.64M | -3.58M | -1.97M | -1.75M | -3.74M | ||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.35M | 0.91M | 0.02M | 0.01M | 0.02M | 0.04M | 0.00M | 0.05M | 0.00M | 0.01M | 0.34M | 1.25M | 0.03M | 0.00M | 0.01M | 0.00M | 0.00M | 0.01M | -992.00 | ||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 229.00 | ||||||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -1.48M | -0.35M | 0.06M | 0.01M | 0.00M | 0.01M | 0.07M | 0.01M | 0.01M | 0.01M | -0.01M | -0.03M | 0.01M | 0.01M | 0.03M | 0.02M | 0.02M | 0.02M | |||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.39M | -0.54M | -0.31M | -8.03M | 3.85M | -0.87M | -3.69M | 0.72M | 0.37M | 0.05M | 0.02M | -0.35M | -1.27M | -0.01M | 0.02M | 0.01M | 0.02M | 0.02M | 0.01M | ||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||
| EBT | -1.77M | -1.32M | -16.91M | -2.02M | -4.82M | -7.09M | -6.17M | -6.25M | -2.56M | -2.29M | -2.71M | -3.50M | -3.09M | -1.98M | 0.64M | -3.59M | -1.97M | -1.75M | -3.75M | ||||||||||||||
| Tax ProvisionsTaxes | -0.06M | ||||||||||||||||||||||||||||||||
| Profit After TaxPAT | -0.91M | -0.96M | -17.20M | -10.04M | -0.95M | -7.92M | -9.86M | -5.48M | -2.19M | -2.24M | -2.69M | -3.50M | -3.12M | -1.97M | 0.66M | -3.56M | -1.95M | -1.73M | -3.73M | ||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | -0.00M | -0.02M | -0.04M | -214.00 | 182.00 | -0.03M | -0.02M | 0.01M | -0.00M | -0.01M | -0.00M | -965.00 | -74.00 | -166.00 | |||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -1.71M | -1.32M | -16.91M | -2.02M | -4.82M | -7.09M | -6.17M | -6.25M | -2.56M | -2.29M | -2.71M | -3.50M | -3.09M | -1.98M | 0.64M | -3.59M | -1.97M | -1.75M | -3.75M | ||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -1.71M | -1.32M | -16.91M | -2.02M | -4.82M | -7.09M | -6.17M | -6.25M | -2.56M | -2.29M | -2.71M | -3.50M | -3.09M | -1.98M | 0.64M | -3.59M | -1.97M | -1.75M | -3.75M | ||||||||||||||
| Income towards Parent CompanyParent Net Inc | -1.71M | -1.32M | -16.91M | -2.02M | -4.82M | -7.09M | -6.17M | -6.25M | -2.56M | -2.29M | -2.71M | -3.50M | -3.09M | -1.98M | 0.64M | -3.59M | -1.97M | -1.75M | -3.75M | ||||||||||||||
| Net Income towards Common StockholdersNet Income | -0.91M | -0.94M | -17.16M | -10.84M | -1.67M | -8.00M | -9.90M | -5.52M | -2.20M | -2.24M | -2.69M | -3.50M | -3.12M | -1.97M | 0.66M | -3.56M | -1.95M | -1.73M | -3.73M | ||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||
| EPS (Basic) | -525.00 | -209.81 | -0.00M | -0.00M | -219.88 | -847.29 | -923.72 | -460.31 | -31.25 | -14.75 | -13.07 | -23.22 | -8.21 | -3.35 | 1.00 | -5.11 | -1.39 | -0.79 | -1.29 | ||||||||||||||
| EPS (Diluted) | -206.40 | -212.72 | -0.00M | -0.00M | -219.88 | -847.29 | -923.72 | -460.31 | -31.25 | -14.75 | -13.07 | -23.22 | -8.21 | -3.35 | 1.00 | -5.11 | -1.39 | -0.79 | -1.29 | ||||||||||||||
| Shares Outstanding | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.07M | 0.15M | 0.21M | 0.15M | 0.38M | 0.59M | 0.66M | 0.70M | 1.40M | 2.20M | 2.89M | 2.56M | |||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.07M | 0.15M | 0.21M | 0.15M | 0.38M | 0.59M | 0.66M | 0.70M | 1.40M | 2.20M | 2.89M | 2.56M | |||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.07M | 0.18M | 0.19M | 0.15M | 0.38M | 0.54M | 0.66M | 0.70M | 1.64M | 2.39M | 3.18M | 2.56M | |||||||||||||
| EBITDA | -0.52M | -0.41M | -16.89M | -2.01M | -4.80M | -7.06M | -6.16M | -6.20M | -2.56M | -2.29M | -2.71M | -3.16M | -1.84M | -1.96M | 0.64M | -3.58M | -1.97M | -1.75M | -3.74M | ||||||||||||||
| Interest ExpensesInt Expense | 0.35M | 0.91M | 0.02M | 0.01M | 0.02M | 0.04M | 0.00M | 0.05M | 0.00M | 0.01M | 0.34M | 1.25M | 0.03M | 0.00M | 0.01M | 0.00M | 0.00M | 0.01M | -992.00 | ||||||||||||||
| Tax Rate | 3.46% |